source
- Pfizer reports flat Q3 revenue as non-COVID sales rise 7% and acquired products grow 32%Pfizer posted third‑quarter revenue of $16.6 billion, essentially unchanged from $16.7 billion a year earlier. The flat top line reflects declines in its legacy Prevnar vaccine and COVID‑related pr…
- Legal experts advise European healthcare manufacturers on navigating complex environmental regulationsAt the RAPS Regulatory Intelligence Conference Europe in Barcelona, two legal specialists highlighted the difficulty of Europe’s environmental and sustainability rules for companies that make healt…